Peg1 Activators
Peg1 activators are a diverse set of chemical compounds that enhance the protein's activity through multiple cellular signaling pathways. Forskolin and Dibutyryl-cAMP (db-cAMP) work to increase intracellular cAMP levels, indirectly leading to the activation of PKA which potentially phosphorylates Peg1, thus enhancing its activity. IBMX supports this mechanism by preventing cAMP degradation, reinforcing the pathway leading to Peg1 activation. The PDE5 inhibitors Sildenafil and Zaprinast raise cGMP levels, which through PKG activation, may contribute to the functional activation of Peg1. L-Arginine, by serving as a substrate for nitric oxide production, may also influence Peg1 activity through the NO-cGMP-PKG signaling axis.
Furthermore, A23187 elevates intracellular calcium concentrations, potentially activating calcium-dependent pathways that could phosphorylate and modify Peg1 activity. PMA, by activating PKC, might phosphorylate Peg1 directly, leading to enhanced functionality. Anisomycin activates the JNK/SAPK signaling pathway, possibly resulting in transcriptional changes that could indirectly enhance Peg1 activity. LY294002, as a PI3K inhibitor, and U0126, as a MEK1/2 inhibitor, might shift cellular signaling to favor pathways that indirectly activate Peg1. Lastly, Nicotinamide mononucleotide (NMN) may influence Peg1 activity by modulating sirtuin activity, which could lead to deacetylation and functional enhancement of Peg1, highlighting the intricate web of intracellular signaling involved in regulating Peg1 activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels within cells. Elevated cAMP activates PKA, which can phosphorylate and thereby enhance the activity of Peg1 by promoting its function in signaling pathways related to growth regulation and metabolic control. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts via its nuclear receptors to alter gene expression. It can indirectly enhance Peg1 activity by promoting differentiation pathways in which Peg1 is an essential mediator, particularly in embryonic development and cell differentiation processes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a potent antioxidant that inhibits various protein kinases. By modulating kinase activity, EGCG can reduce phosphorylation-based inhibitory controls on Peg1, thus indirectly enhancing its functional role in cell signaling related to growth and apoptosis. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that acts via S1P receptors to modulate a variety of signaling pathways. It can potentiate Peg1 activity by activating signaling cascades involved in cell survival and proliferation where Peg1 is implicated. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase. Elevated calcium can enhance Peg1 activity by stimulating calcium-dependent signaling mechanisms that Peg1 is part of. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol inhibits phosphodiesterase type 3, leading to increased cAMP levels. This can indirectly enhance Peg1's signaling role in vascular function and platelet aggregation by augmenting the PKA signaling pathway. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
CHIR99021 is a GSK-3β inhibitor that activates the Wnt signaling pathway. By stabilizing β-catenin, it can indirectly enhance Peg1 activity involved in cell proliferation, differentiation, and embryogenesis. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium nitroprusside releases nitric oxide, which activates guanylate cyclase and increases cGMP levels. This can enhance Peg1 activity indirectly by influencing signaling pathways related to vascular tone and angiogenesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A affects chromatin structure and gene expression. It can enhance Peg1 activity by altering the transcriptional regulation of genes within pathways where Peg1 plays a role, especially in cell cycle regulation and differentiation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as an activator of the protein synthesis pathway through c-Met/HGFR signaling. It can enhance Peg1 activity by influencing cellular pathways related to growth, motility, and morphogenesis. | ||||||